Showing results (561-570 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|January 8, 2026
Genomic Profile and Resistance to Anti-Epidermal Growth Factor Receptor Antibody in RAS-Amplified Colorectal Cancer: A Study Based on a Japanese Cancer Genome DatabaseGota Fujisawa, Kenji Tamada, Takeshi Hayashi, et al.
JCO Precision Oncology|December 18, 2025
Tumor Mutations in Minority Populations Versus Non-Hispanic Whites Across Tumor TypesJonathan Coy, Isabella Doan, Devon Chabot-Richards, et al.
JCO Precision Oncology|December 18, 2025
Timing of Adjuvant Chemotherapy After Gastrectomy in Patients With Stage II to III Gastric Cancer: A Target Trial Emulation StudyCheng Zhang, Lian Jin, Jiayi Wang, et al.
JCO Precision Oncology|December 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute LeukemiaHannah Goulart, Farhad Ravandi, Nicholas J Short, et al.
JCO Precision Oncology|December 10, 2025
Magnetic Resonance Imaging-Detected High-Risk Markers in Rectal Cancer Patients With a Pathologic Complete Response After Neoadjuvant TherapyKe Zhao, Minning Zhao, Qing-Yang Li, et al.
JCO Precision Oncology|December 5, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma RegistrySara A Walton, Justin J Kim, Francesco Paoloni, et al.
JCO Precision Oncology|December 1, 2025
Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition GenesMichelle F Jacobs, Sarah Austin, Andrea M Murad, et al.
JCO Precision Oncology|December 10, 2025
Development and Validation of an Intratumor Heterogeneity-Based Prognostic Model for Clear Cell Renal Cell CarcinomaValbert Oliveira Costa Filho, Pedro Robson Costa Passos, Mariana Macambira Noronha, et al.
JCO Precision Oncology|February 12, 2025
Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology ClinicHassan Sinan, Dea Cunningham, Emy Abou Sleiman, et al.
JCO Precision Oncology|December 18, 2024
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol UMarjorie G Zauderer, Opeyemi Jegede, David M Jackman, et al.
Pageof 140